Outcomes, health-care resources use, and costs of endoscopic removal of metallic airway stents

Saleh Alazemi, William Lunn, Adnan Majid, David Berkowitz, Gaetane Michaud, David Feller-Kopman, Felix Herth, Armin Ernst

Research output: Contribution to journalArticle

Abstract

Background: The use of self-expandable metallic airway stents (SEMAS) for airway compromise may be associated with significant complications requiring their removal/replacement. The aim of this study is to describe the complications, health-care resources use (HRU), and costs associated with endoscopic removal of SEMAS. Methods: A retrospective analysis of patients who underwent endoscopic removal of SEMAS during a 10-year period (January 2000-August 2009) was performed. HRU was analyzed in terms of the number of endoscopic procedures, hospital and ICU stay, need for mechanical ventilation and airway restenting, and estimation of respective hospital costs. Results: Fifty-five SEMAS were removed from 46 patients with a mean age of 58.6 ± 15.8 years. Eighty percent of the stents were placed for benign airway disorders with an average stent in situ duration of 292 days. The median number of removal and total procedures during each encounter was one and two, respectively. Patients required hospitalization and ICU admission in 78% and 39% of the encounters with a median length of stay of 3.5 and 0 days, respectively. The estimated median total cost per encounter to remove the stents was $10,700, ranging from $3,700 to $69,800. The measured outcomes were statistically significantly better when in situ stent duration was ≤ 30 days (P <.05). Conclusions: Endoscopic removal of SEMAS is feasible; however, it is associated with significant complications, HRU, and costs. The use of SEMAS should be restricted to a well-selected patient population and should be planned by a team experienced with this type of therapeutic strategy.

Original languageEnglish (US)
Pages (from-to)350-356
Number of pages7
JournalChest
Volume138
Issue number2
DOIs
StatePublished - Aug 1 2010

Fingerprint

Health Resources
Stents
Delivery of Health Care
Costs and Cost Analysis
Length of Stay
Hospital Costs
Artificial Respiration
Self Expandable Metallic Stents
Hospitalization
Population

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine
  • Critical Care and Intensive Care Medicine
  • Cardiology and Cardiovascular Medicine

Cite this

Alazemi, S., Lunn, W., Majid, A., Berkowitz, D., Michaud, G., Feller-Kopman, D., ... Ernst, A. (2010). Outcomes, health-care resources use, and costs of endoscopic removal of metallic airway stents. Chest, 138(2), 350-356. https://doi.org/10.1378/chest.09-2682

Outcomes, health-care resources use, and costs of endoscopic removal of metallic airway stents. / Alazemi, Saleh; Lunn, William; Majid, Adnan; Berkowitz, David; Michaud, Gaetane; Feller-Kopman, David; Herth, Felix; Ernst, Armin.

In: Chest, Vol. 138, No. 2, 01.08.2010, p. 350-356.

Research output: Contribution to journalArticle

Alazemi, S, Lunn, W, Majid, A, Berkowitz, D, Michaud, G, Feller-Kopman, D, Herth, F & Ernst, A 2010, 'Outcomes, health-care resources use, and costs of endoscopic removal of metallic airway stents', Chest, vol. 138, no. 2, pp. 350-356. https://doi.org/10.1378/chest.09-2682
Alazemi, Saleh ; Lunn, William ; Majid, Adnan ; Berkowitz, David ; Michaud, Gaetane ; Feller-Kopman, David ; Herth, Felix ; Ernst, Armin. / Outcomes, health-care resources use, and costs of endoscopic removal of metallic airway stents. In: Chest. 2010 ; Vol. 138, No. 2. pp. 350-356.
@article{c27356f958554a439fcb5b031690b56f,
title = "Outcomes, health-care resources use, and costs of endoscopic removal of metallic airway stents",
abstract = "Background: The use of self-expandable metallic airway stents (SEMAS) for airway compromise may be associated with significant complications requiring their removal/replacement. The aim of this study is to describe the complications, health-care resources use (HRU), and costs associated with endoscopic removal of SEMAS. Methods: A retrospective analysis of patients who underwent endoscopic removal of SEMAS during a 10-year period (January 2000-August 2009) was performed. HRU was analyzed in terms of the number of endoscopic procedures, hospital and ICU stay, need for mechanical ventilation and airway restenting, and estimation of respective hospital costs. Results: Fifty-five SEMAS were removed from 46 patients with a mean age of 58.6 ± 15.8 years. Eighty percent of the stents were placed for benign airway disorders with an average stent in situ duration of 292 days. The median number of removal and total procedures during each encounter was one and two, respectively. Patients required hospitalization and ICU admission in 78{\%} and 39{\%} of the encounters with a median length of stay of 3.5 and 0 days, respectively. The estimated median total cost per encounter to remove the stents was $10,700, ranging from $3,700 to $69,800. The measured outcomes were statistically significantly better when in situ stent duration was ≤ 30 days (P <.05). Conclusions: Endoscopic removal of SEMAS is feasible; however, it is associated with significant complications, HRU, and costs. The use of SEMAS should be restricted to a well-selected patient population and should be planned by a team experienced with this type of therapeutic strategy.",
author = "Saleh Alazemi and William Lunn and Adnan Majid and David Berkowitz and Gaetane Michaud and David Feller-Kopman and Felix Herth and Armin Ernst",
year = "2010",
month = "8",
day = "1",
doi = "10.1378/chest.09-2682",
language = "English (US)",
volume = "138",
pages = "350--356",
journal = "Chest",
issn = "0012-3692",
publisher = "American College of Chest Physicians",
number = "2",

}

TY - JOUR

T1 - Outcomes, health-care resources use, and costs of endoscopic removal of metallic airway stents

AU - Alazemi, Saleh

AU - Lunn, William

AU - Majid, Adnan

AU - Berkowitz, David

AU - Michaud, Gaetane

AU - Feller-Kopman, David

AU - Herth, Felix

AU - Ernst, Armin

PY - 2010/8/1

Y1 - 2010/8/1

N2 - Background: The use of self-expandable metallic airway stents (SEMAS) for airway compromise may be associated with significant complications requiring their removal/replacement. The aim of this study is to describe the complications, health-care resources use (HRU), and costs associated with endoscopic removal of SEMAS. Methods: A retrospective analysis of patients who underwent endoscopic removal of SEMAS during a 10-year period (January 2000-August 2009) was performed. HRU was analyzed in terms of the number of endoscopic procedures, hospital and ICU stay, need for mechanical ventilation and airway restenting, and estimation of respective hospital costs. Results: Fifty-five SEMAS were removed from 46 patients with a mean age of 58.6 ± 15.8 years. Eighty percent of the stents were placed for benign airway disorders with an average stent in situ duration of 292 days. The median number of removal and total procedures during each encounter was one and two, respectively. Patients required hospitalization and ICU admission in 78% and 39% of the encounters with a median length of stay of 3.5 and 0 days, respectively. The estimated median total cost per encounter to remove the stents was $10,700, ranging from $3,700 to $69,800. The measured outcomes were statistically significantly better when in situ stent duration was ≤ 30 days (P <.05). Conclusions: Endoscopic removal of SEMAS is feasible; however, it is associated with significant complications, HRU, and costs. The use of SEMAS should be restricted to a well-selected patient population and should be planned by a team experienced with this type of therapeutic strategy.

AB - Background: The use of self-expandable metallic airway stents (SEMAS) for airway compromise may be associated with significant complications requiring their removal/replacement. The aim of this study is to describe the complications, health-care resources use (HRU), and costs associated with endoscopic removal of SEMAS. Methods: A retrospective analysis of patients who underwent endoscopic removal of SEMAS during a 10-year period (January 2000-August 2009) was performed. HRU was analyzed in terms of the number of endoscopic procedures, hospital and ICU stay, need for mechanical ventilation and airway restenting, and estimation of respective hospital costs. Results: Fifty-five SEMAS were removed from 46 patients with a mean age of 58.6 ± 15.8 years. Eighty percent of the stents were placed for benign airway disorders with an average stent in situ duration of 292 days. The median number of removal and total procedures during each encounter was one and two, respectively. Patients required hospitalization and ICU admission in 78% and 39% of the encounters with a median length of stay of 3.5 and 0 days, respectively. The estimated median total cost per encounter to remove the stents was $10,700, ranging from $3,700 to $69,800. The measured outcomes were statistically significantly better when in situ stent duration was ≤ 30 days (P <.05). Conclusions: Endoscopic removal of SEMAS is feasible; however, it is associated with significant complications, HRU, and costs. The use of SEMAS should be restricted to a well-selected patient population and should be planned by a team experienced with this type of therapeutic strategy.

UR - http://www.scopus.com/inward/record.url?scp=77955043075&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77955043075&partnerID=8YFLogxK

U2 - 10.1378/chest.09-2682

DO - 10.1378/chest.09-2682

M3 - Article

C2 - 20495103

AN - SCOPUS:77955043075

VL - 138

SP - 350

EP - 356

JO - Chest

JF - Chest

SN - 0012-3692

IS - 2

ER -